FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean
Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics
Daniel Lenihan, MD and Douglas B. Sawyer, MD, PhD
Please call 1-800-545-2522 for availability
As the number of effective anti-neoplastic agents has grown, there has been a concomitant increase in side effects. Cardiotoxicity, and specifically LV dysfunction, remains the limiting factor for many such agents, and is the focus of growing research and clinical emphasis. This issue summarizes for the heart failure specialist the possible ways that chemotherapeutic agents might cause cardiotoxicity as well as the methods for detecting, treating and preventing cardiotoxicity.
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and mobile, we are able to supply the information you need in the most convenient format.